一种工程预制药在混合微生物环境中选择性地抑制β-乳酸盐耐药细菌
Addison M Duda1, Helena R Ma2, César A Villalobos2
1Department of Chemistry, Duke University, Durham, NC 27710, USA.
bioRxiv : the preprint server for biology
|August 12, 2024
概括
新的前药AcephPT针对具有扩展光谱β-乳酸酶 (ESBLs) 的细菌. 这种方法选择性地抑制了耐药菌株,提供了针对抗菌素耐药性的新战略,并促进了负责任的抗生素使用.
科学领域:
- 微生物学 微生物学
- 药用化学 医学化学
- 计算生物学 计算生物学
背景情况:
- 抗菌素耐药性,特别是对β-乳糖抗生素的耐药性,是一个日益增长的全球健康威胁.
- 现有的治疗方法面临挑战,原因是抗药机制的出现,如扩展光谱β-乳酸酶 (ESBL).
研究的目的:
- 设计一种新的β-乳糖原药AcephPT,用于选择性向和抑制产生ESBL的细菌.
- 开发一种利用β-乳糖酶活性进行向抗菌作用的策略.
主要方法:
- 计算机建模引导前药AcephPT的结构修改.
- 使用克隆种群和混合微生物培养的体外实验.
- 时间过程核磁共振 (NMR) 谱学以确认前药物激活.
主要成果:
- AcephPT证明了选择性抑制产生ESBL的グラム阴性细菌,包括临床分离物.
- 核磁共振研究证实了ESBL产生细菌对AcephPT的排他性水解激活.
- 在混合培养中,acephPT抑制了产生ESBL的菌株,同时允许非生产细菌生长.
结论:
- AcephPT有效地向和抑制ESBL产生细菌,提供了一个新的治疗途径.
- 这种选择性方法对抗β-乳酸盐耐药性和支持抗微生物药物管理具有前景.
相关概念视频
Combined Effects of Drugs: Synergism
3.8K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
3.8K
Antibiotic Selection
52.7K
Overview
52.7K
Defense Against Bacterial Pathogens
1.4K
The human immune system is a complex network of cells, tissues, and organs that work together to defend the body against bacterial infections. It consists of various immune cells, each playing a specific role in the defense mechanism.
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
1.4K
Prodrugs
2.6K
Prodrugs are a class of pharmaceutical compounds that undergo a biotransformation process within the body to be converted into a pharmacologically active drug. Prodrugs are designed to improve the therapeutic properties of the parent drug, such as enhancing bioavailability, increasing stability, or reducing toxicity. The concept of prodrugs revolves around modifying the chemical structure of the original drug to make it more effective or convenient for administration.
Prodrugs help overcome...
Prodrugs help overcome...
2.6K


